335 related articles for article (PubMed ID: 12344725)
1. Most providers comfortable giving OCs to women over age 40. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):158-9. PubMed ID: 12344725
[TBL] [Abstract][Full Text] [Related]
2. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
3. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
4. Consider prescribing OCs for perimenopause use.
Contracept Technol Update; 2000 Mar; 21(3):31-3. PubMed ID: 12349548
[TBL] [Abstract][Full Text] [Related]
5. Approaches vary in managing the over-40 pill patient.
Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
[TBL] [Abstract][Full Text] [Related]
6. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
7. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
[TBL] [Abstract][Full Text] [Related]
8. Debate continues over OC use by women over age 40.
Contracept Technol Update; 1988 Sep; 9(9):101-5. PubMed ID: 12342191
[TBL] [Abstract][Full Text] [Related]
9. Experts debate pill switching to combat noncompliance. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):149-53. PubMed ID: 12344722
[TBL] [Abstract][Full Text] [Related]
10. Young teens are safe on pills but need counseling, follow-up.
Contracept Technol Update; 1987 Sep; 8(9):120-2. PubMed ID: 12268914
[TBL] [Abstract][Full Text] [Related]
11. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
12. Pills remain the top choice among reversible contraceptive options.
Contracept Technol Update; 1999 Sep; 20(9):97-101. PubMed ID: 12290380
[TBL] [Abstract][Full Text] [Related]
13. OCs: international experts discuss state-of-the-art.
Contracept Technol Update; 1981 Nov; 2(11):147-51. PubMed ID: 12338027
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraception: evolution of concepts over the last thirty years].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
[TBL] [Abstract][Full Text] [Related]
15. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
[TBL] [Abstract][Full Text] [Related]
16. OCs are currently the second most popular birth control method in U.S.
Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916
[TBL] [Abstract][Full Text] [Related]
17. On 7/7/7 preferred for new patients by 47% of respondents.
Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
[TBL] [Abstract][Full Text] [Related]
18. Clinicians cautious in prescribing OCs for patients age 40 and over.
Contracept Technol Update; 1987 Sep; 8(9):114-7. PubMed ID: 12268912
[TBL] [Abstract][Full Text] [Related]
19. Pill power: oral contraceptives hold top spot in family planning arsenal.
Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
[TBL] [Abstract][Full Text] [Related]
20. Should oral contraceptives be sold over-the-counter?
Stone SC
Am J Gynecol Health; 1993; 7(2):27-32. PubMed ID: 12319537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]